July 17, 2024


Learn new things

Pressure BioSciences, Inc. to Discuss Third Quarter 2020 Money Outcomes and Give Enterprise Update

The MarketWatch News Division was not associated in the creation of this articles.

SOUTH EASTON, Mass., Nov. 16, 2020 /PRNewswire through COMTEX/ —
SOUTH EASTON, Mass., Nov. 16, 2020 /PRNewswire/ — Force BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Enterprise”) right now announced that the Organization will host a teleconference to examine its Third Quarter 2020 fiscal success and to present a business enterprise update. Anyone interested may possibly pay attention to the teleconference either are living (by phone) or through a replay (by phone or via a link on the Firm’s site) approximately a single day right after the teleconference.

The teleconference will involve a Organization presentation followed by a Query & Remedy period.

Date:  Tuesday, November 17, 2020.  
Time:  4:30 PM Japanese Time (ET).

To attend this teleconference, stay by telephone: Dial-in: (877) 407-8033 (North The usa) (201) 689-8033 (Global). Verbal Passcode: PBI 3rd Quarter 2020 Monetary Simply call & Organization Update.

For individuals unable to take part in the dwell teleconference, a replay will be readily available commencing Wednesday, November 18, 2020.  The replay will be obtainable via phone and the Firm’s website for 30 days.

Replay Quantity: (877) 481-4010 (North America) (919) 882-2331 (Int’l) Replay Passcode: 38901.

About Force BioSciences, Inc.

Strain BioSciences, Inc. (OTCQB: PBIO) is a leader in the advancement and sale of progressive, broadly enabling, tension-based solutions for the globally daily life sciences and other industries. Our products are dependent on the special houses of both of those constant (i.e., static) and alternating (i.e., strain cycling technological innovation, or PCT) hydrostatic force. PCT is a patented enabling know-how platform that employs alternating cycles of hydrostatic stress in between ambient and extremely-high levels to control biomolecular interactions properly and reproducibly (e.g., mobile lysis, biomolecule extraction). Our key concentrate is in the development of PCT-primarily based merchandise for biomarker and goal discovery, drug layout and development, biotherapeutics characterization and high quality command, soil & plant biology, forensics, and counter-bioterror purposes. Additionally, main new industry chances have emerged in the use of our strain-primarily based technologies in the following parts: (1) the use of our just lately obtained, patented know-how from BaroFold, Inc. (the “BaroFold” technological know-how) to enable entry into the bio-pharma agreement products and services sector, and (2) the use of our just lately-patented, scalable, large-effectiveness, tension-centered Ultra Shear Technological know-how (“UST”) system to (i) make stable nanoemulsions of in any other case immiscible fluids (e.g., oils and h2o) and to (ii) get ready larger good quality, homogenized, extended shelf-everyday living or room temperature stable lower-acid liquid foodstuff that are unable to be properly preserved making use of present non-thermal technologies.

For extra facts about PBI and this press release, please click on the adhering to link: http://www.pressurebiosciences.com

Please stop by us on Facebook, LinkedIn, and Twitter. 

Trader Contacts

Richard T. Schumacher, President & CEO, (T) 508-230-1828, Jeffrey N. Peterson, Chairman of the Board, (F) 508-230-1829



View authentic content material:http://www.prnewswire.com/news-releases/stress-biosciences-inc-to-explore-3rd-quarter-2020-economic-success-and-give-organization-update-301173928.html

Supply Pressure BioSciences, Inc.


Is there a dilemma with this push launch? Speak to the source supplier Comtex at [email protected]. You can also make contact with MarketWatch Client Company by means of our Client Centre.

Copyright (C) 2020 PR Newswire. All rights reserved

The MarketWatch News Section was not involved in the generation of this information.